Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Id-1, Id-2, and Id-3co-expression correlates with prognosis in stage I and II lung adenocarcinoma patients treated with surgery and adjuvant chemotherapy

Full text
Author(s):
Antonangelo, Leila [1] ; Tuma, Taila [1] ; Fabro, Alexandre [1] ; Acencio, Milena [2] ; Terra, Ricardo [2] ; Parra, Edwin [1] ; Vargas, Francisco [2] ; Takagaki, Teresa [2] ; Capelozzi, Vera [1]
Total Authors: 9
Affiliation:
[1] Univ Sao Paulo, Dept Pathol, BR-01246903 Sao Paulo - Brazil
[2] Univ Sao Paulo, Div Pulm, Inst Heart, Clin Hosp, BR-01246903 Sao Paulo - Brazil
Total Affiliations: 2
Document type: Journal article
Source: Experimental Biology and Medicine; v. 241, n. 11, p. 1159-1168, JUN 2016.
Web of Science Citations: 2
Abstract

Inhibitors of DNA binding/inhibitors of differentiation (Id) protein family have been shown to be involved in carcinogenesis. However, the roles of Id during lung adenocarcinoma (ADC) progression remain unclear. Eighty-eight ADC samples were evaluated for Id-1,2,3 level and angiogenesis (CD 34 and VEGF microvessel density) by immunohistochemistry and morphometry. The impact of these markers was tested on follow-up until death or recurrence. A significant difference between tumor and normal tissue was found for Id-1,2,3 expression (P < 0.01). In addition, high levels of nuclear Id-1 were associated with higher angiogenesis in the tumor stroma (P < 0.01). Equally significant was the association between patients in T1-stage and low cytoplasmic Id-2, as well as patients in stage-IIb and low Id-3. High cytoplasm Id-3 expression was also directly associated to lymph nodes metastasis (P = 0.05). Patients at stages I to III, with low Id-1 and Id-3 cytoplasm histoscores showed significant long metastasis-free survival time than those with high Id-1 or Id-3 expression (P = 0.04). Furthermore, high MVD-CD34 and MVD-VEGF expression were associated with short recurrence-free survival compared to low MVD-CD34 and MVD-VEGF expressions (P = 0.04). Cox model analyses controlled for age, lymph node metastasis, and adjuvant treatments showed that nuclear Id-1, cytoplasmic Id-3, and MVD-CD34 were significantly associated with survival time. Median score for nuclear Id-1 and cytoplasmic Id-3 divided patients in two groups, being that those with increased Id-1 and Id-3 presented higher risk of death. Ids showed an independent prognostic value in patients with lung ADC, regardless of disease stage. Id-1 and Id-3 should be considered new target candidates in the development of personalized therapy in lung ADC. (AU)

FAPESP's process: 13/14277-4 - Prognosis and clinical evolution of new and current genetic and proteic biomarkers in lung cancer
Grantee:Vera Luiza Capelozzi
Support Opportunities: Regular Research Grants
FAPESP's process: 11/52095-0 - Evaluation of the frequency of EGFR, KRAS and EML4-ALK mutation in adenocarcinomas and their subtypes and impact of expression of hyaluronidases and hyaluronic acid synthase in pre-neoplastic lung lesions
Grantee:Vera Luiza Capelozzi
Support Opportunities: Regular Research Grants